| Code | Description | Claims | Beneficiaries | Total Paid |
| 0450 |
Emergency room services |
79,448 |
70,181 |
$4.23M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
51,581 |
49,032 |
$507K |
| 99205 |
Prolong outpt/office vis |
4,431 |
4,236 |
$316K |
| 99199 |
Unlisted special service, procedure or report |
6,934 |
6,443 |
$291K |
| 0206 |
|
1,920 |
626 |
$208K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
25,855 |
24,060 |
$185K |
| 0510 |
|
11,251 |
10,004 |
$160K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
4,526 |
3,784 |
$134K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
24,649 |
23,547 |
$132K |
| 0200 |
|
815 |
228 |
$122K |
| 0131 |
Inj, acetaminophen (hikma) |
119 |
112 |
$122K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
12,096 |
11,694 |
$95K |
| G9008 |
Coordinated care fee, physician coordinated care oversight services |
7,466 |
5,495 |
$91K |
| 99215 |
Prolong outpt/office vis |
12,201 |
11,177 |
$79K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,679 |
1,547 |
$71K |
| 0111 |
|
110 |
65 |
$65K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
4,695 |
3,694 |
$53K |
| 0760 |
|
2,320 |
1,969 |
$50K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
12,839 |
12,465 |
$47K |
| 99221 |
|
1,741 |
1,500 |
$45K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
2,134 |
2,085 |
$32K |
| 90715 |
|
4,851 |
4,537 |
$30K |
| G0384 |
Level 5 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
78 |
78 |
$25K |
| 74174 |
|
5,329 |
5,128 |
$21K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,513 |
1,383 |
$19K |
| 92100 |
|
1,818 |
1,698 |
$16K |
| 92250 |
|
4,413 |
4,140 |
$16K |
| 70450 |
Computed tomography, head or brain; without contrast material |
5,128 |
4,793 |
$15K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,184 |
1,005 |
$15K |
| 0100 |
|
10,713 |
2,313 |
$13K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
2,416 |
2,226 |
$12K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
4,822 |
4,295 |
$12K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
1,126 |
927 |
$11K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
5,046 |
4,687 |
$11K |
| J1815 |
Injection, insulin, per 5 units |
477 |
126 |
$10K |
| G9012 |
Other specified case management service not elsewhere classified |
17 |
13 |
$9K |
| 71045 |
Radiologic examination, chest; single view |
17,396 |
14,229 |
$9K |
| 80053 |
Comprehensive metabolic panel |
23,063 |
19,859 |
$9K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
3,426 |
3,111 |
$8K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
514 |
507 |
$8K |
| 76770 |
|
782 |
772 |
$8K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
76,218 |
69,943 |
$8K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
50,521 |
44,467 |
$7K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
20,668 |
16,744 |
$7K |
| 71046 |
Radiologic examination, chest; 2 views |
22,600 |
21,639 |
$7K |
| 87536 |
|
952 |
939 |
$7K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,598 |
2,397 |
$6K |
| 92082 |
|
1,763 |
1,735 |
$6K |
| 93971 |
|
3,467 |
3,212 |
$6K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
26,280 |
23,558 |
$5K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
3,705 |
3,576 |
$5K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
15,537 |
15,025 |
$5K |
| 92285 |
|
1,064 |
969 |
$5K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
3,842 |
3,773 |
$5K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
337 |
327 |
$5K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
712 |
707 |
$5K |
| 80061 |
Lipid panel |
10,138 |
9,910 |
$5K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
4,543 |
4,312 |
$5K |
| 78816 |
|
12 |
12 |
$5K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
5,644 |
5,405 |
$4K |
| 87522 |
Neg quan hep c or qual rna |
3,184 |
3,108 |
$4K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
5,740 |
5,642 |
$4K |
| 90670 |
|
610 |
521 |
$4K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
18,960 |
15,887 |
$4K |
| 84443 |
Thyroid stimulating hormone (TSH) |
5,639 |
5,458 |
$4K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
612 |
602 |
$4K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
341 |
308 |
$4K |
| 0516 |
|
176 |
167 |
$4K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
18,723 |
10,670 |
$4K |
| 73564 |
|
3,628 |
3,455 |
$4K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
843 |
834 |
$3K |
| 90698 |
|
1,158 |
985 |
$3K |
| 86480 |
|
1,898 |
1,805 |
$3K |
| 92134 |
|
5,456 |
5,168 |
$3K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,995 |
1,968 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
7,501 |
7,237 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
50,473 |
46,253 |
$3K |
| 71250 |
|
205 |
197 |
$3K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
2,080 |
1,587 |
$3K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
11,770 |
11,288 |
$3K |
| 76827 |
|
527 |
481 |
$3K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
54 |
52 |
$3K |
| 92132 |
|
353 |
347 |
$3K |
| 86359 |
|
653 |
653 |
$2K |
| 99381 |
|
496 |
458 |
$2K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
570 |
499 |
$2K |
| 92557 |
|
1,897 |
1,803 |
$2K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,530 |
1,497 |
$2K |
| 73630 |
|
4,106 |
3,813 |
$2K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
61,777 |
55,832 |
$2K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
575 |
419 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
5,784 |
5,532 |
$2K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
688 |
632 |
$2K |
| 90935 |
Hemodialysis procedure with single evaluation by a physician |
1,546 |
758 |
$2K |
| 73130 |
|
2,702 |
2,350 |
$2K |
| 76642 |
|
260 |
256 |
$2K |
| 88342 |
|
2,655 |
2,550 |
$2K |
| 73610 |
|
3,140 |
2,842 |
$2K |
| 93247 |
|
965 |
896 |
$2K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
403 |
400 |
$2K |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
537 |
511 |
$2K |
| 73110 |
|
2,446 |
2,098 |
$2K |
| 92133 |
|
1,459 |
1,422 |
$2K |
| 73200 |
|
414 |
402 |
$2K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
11,093 |
9,952 |
$2K |
| 73590 |
|
2,042 |
1,862 |
$2K |
| 86703 |
|
3,457 |
3,390 |
$2K |
| 74183 |
|
40 |
39 |
$1K |
| 93926 |
|
480 |
444 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,320 |
1,223 |
$1K |
| 73030 |
|
2,074 |
1,949 |
$1K |
| 83970 |
|
371 |
354 |
$1K |
| 82043 |
|
5,334 |
5,068 |
$1K |
| 80076 |
|
2,437 |
2,122 |
$1K |
| 83735 |
|
6,547 |
3,991 |
$1K |
| 85027 |
|
6,432 |
5,189 |
$1K |
| 86780 |
|
2,336 |
2,293 |
$1K |
| 20610 |
|
997 |
898 |
$1K |
| 73700 |
|
322 |
315 |
$1K |
| 90710 |
|
1,235 |
1,025 |
$1K |
| Q3014 |
Telehealth originating site facility fee |
487 |
423 |
$1K |
| 88341 |
|
258 |
250 |
$1K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
603 |
579 |
$1K |
| 84439 |
|
2,091 |
2,024 |
$996.08 |
| 74170 |
|
25 |
25 |
$972.13 |
| 90744 |
|
812 |
695 |
$963.27 |
| 85610 |
|
6,223 |
4,732 |
$961.34 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
10,908 |
10,401 |
$948.16 |
| 84702 |
|
1,117 |
803 |
$940.51 |
| 77065 |
Tomosynthesis, mammo |
29 |
28 |
$927.59 |
| 82540 |
|
4,900 |
4,677 |
$920.01 |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
15 |
14 |
$918.02 |
| 84153 |
|
1,430 |
1,301 |
$908.22 |
| 81001 |
|
10,967 |
10,125 |
$904.60 |
| 73080 |
|
979 |
882 |
$900.31 |
| 86850 |
|
1,967 |
1,683 |
$888.62 |
| 36415 |
Collection of venous blood by venipuncture |
278,300 |
209,359 |
$866.48 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
4,124 |
3,981 |
$857.32 |
| 85730 |
|
2,797 |
2,249 |
$844.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,831 |
1,072 |
$823.35 |
| 82728 |
|
1,663 |
1,626 |
$819.86 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
6,183 |
5,638 |
$787.26 |
| 76870 |
|
411 |
400 |
$786.81 |
| 76830 |
Ultrasound, transvaginal |
317 |
313 |
$779.32 |
| 97161 |
|
4,914 |
4,534 |
$715.70 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
1,782 |
1,617 |
$713.33 |
| 76801 |
|
389 |
373 |
$706.45 |
| 93880 |
|
286 |
265 |
$702.56 |
| 84100 |
|
6,001 |
3,574 |
$700.48 |
| 0250 |
|
2,374 |
2,064 |
$690.17 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
5,543 |
4,968 |
$671.24 |
| 76536 |
|
161 |
158 |
$646.43 |
| 87340 |
|
2,160 |
2,123 |
$646.30 |
| 72170 |
|
695 |
659 |
$625.12 |
| 97162 |
|
3,628 |
3,328 |
$588.65 |
| 76512 |
|
205 |
199 |
$584.92 |
| 86706 |
|
1,478 |
1,454 |
$582.12 |
| 86900 |
|
2,016 |
1,729 |
$577.40 |
| 86901 |
|
2,466 |
2,129 |
$571.13 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
110,597 |
84,389 |
$564.89 |
| 82274 |
|
10,984 |
9,560 |
$541.80 |
| 70491 |
|
49 |
49 |
$535.90 |
| 90677 |
|
2,905 |
2,596 |
$527.15 |
| 86140 |
|
1,934 |
1,859 |
$524.13 |
| 93307 |
|
79 |
75 |
$516.56 |
| 97010 |
|
2,472 |
1,572 |
$510.80 |
| 84481 |
|
456 |
441 |
$503.20 |
| 83880 |
|
237 |
206 |
$487.65 |
| 73090 |
|
750 |
687 |
$484.78 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
2,889 |
2,737 |
$474.46 |
| 86705 |
|
923 |
908 |
$468.86 |
| 92550 |
|
638 |
595 |
$468.15 |
| 84484 |
|
835 |
713 |
$467.85 |
| 82607 |
|
1,196 |
1,179 |
$454.07 |
| 83550 |
|
1,405 |
1,384 |
$449.17 |
| 83540 |
|
1,529 |
1,508 |
$446.42 |
| 75574 |
|
29 |
28 |
$431.02 |
| 92567 |
|
1,149 |
1,067 |
$430.46 |
| 72100 |
|
559 |
541 |
$429.90 |
| 70498 |
|
79 |
78 |
$429.81 |
| 29705 |
|
1,215 |
1,025 |
$404.67 |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
1,120 |
878 |
$400.38 |
| 73552 |
|
305 |
296 |
$389.25 |
| 73140 |
|
1,297 |
1,157 |
$385.03 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
650 |
632 |
$384.30 |
| 92551 |
|
1,207 |
1,105 |
$367.28 |
| J2704 |
Injection, propofol, 10 mg |
5,255 |
4,860 |
$367.20 |
| 97166 |
|
877 |
778 |
$359.33 |
| 80305 |
|
4,386 |
3,884 |
$358.97 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
13,108 |
10,610 |
$355.15 |
| 99442 |
|
45,424 |
41,930 |
$354.45 |
| 86160 |
|
298 |
289 |
$348.19 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
2,163 |
2,029 |
$341.07 |
| 81025 |
|
2,853 |
2,695 |
$335.00 |
| 10060 |
|
12 |
12 |
$318.55 |
| 90723 |
|
134 |
125 |
$315.51 |
| 85652 |
|
1,956 |
1,885 |
$311.17 |
| 51798 |
|
629 |
584 |
$309.37 |
| 88307 |
|
775 |
756 |
$304.96 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,718 |
1,208 |
$302.56 |
| 93308 |
|
956 |
898 |
$297.54 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
6,349 |
4,701 |
$290.71 |
| 51702 |
|
428 |
368 |
$290.48 |
| 90651 |
|
1,626 |
1,483 |
$288.34 |
| 87186 |
|
2,096 |
1,970 |
$287.93 |
| 29075 |
|
315 |
294 |
$287.43 |
| 82746 |
|
360 |
355 |
$285.70 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,404 |
1,354 |
$283.97 |
| 92227 |
|
2,269 |
2,060 |
$271.94 |
| 52000 |
|
120 |
109 |
$271.79 |
| 76825 |
|
274 |
245 |
$267.77 |
| 82378 |
|
246 |
189 |
$261.88 |
| 12001 |
|
13 |
13 |
$260.29 |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
239 |
234 |
$253.02 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
12,282 |
10,844 |
$248.92 |
| 92228 |
|
425 |
351 |
$238.37 |
| 82565 |
|
3,262 |
2,960 |
$229.50 |
| 85007 |
|
2,113 |
1,556 |
$222.62 |
| 90739 |
|
1,062 |
976 |
$220.23 |
| 0296T |
|
207 |
202 |
$218.18 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
492 |
264 |
$215.79 |
| 82570 |
|
1,182 |
1,066 |
$209.78 |
| 73620 |
|
306 |
296 |
$202.09 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
5,526 |
5,197 |
$202.01 |
| 90750 |
|
2,784 |
2,594 |
$200.34 |
| 76775 |
|
169 |
167 |
$189.78 |
| 99242 |
|
429 |
404 |
$184.91 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
14,851 |
12,104 |
$180.70 |
| 99443 |
|
14,700 |
13,762 |
$179.67 |
| 86592 |
|
1,184 |
1,135 |
$177.48 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,894 |
1,832 |
$173.69 |
| 98960 |
|
2,902 |
1,746 |
$169.10 |
| 90633 |
|
1,368 |
1,151 |
$163.48 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
5,251 |
3,658 |
$162.94 |
| 90694 |
|
44 |
42 |
$162.00 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
1,308 |
1,237 |
$159.44 |
| 87088 |
|
3,202 |
2,968 |
$159.07 |
| 74018 |
|
956 |
799 |
$154.42 |
| 99441 |
|
20,333 |
19,127 |
$151.99 |
| 84403 |
|
149 |
135 |
$151.69 |
| 81003 |
|
2,567 |
2,390 |
$149.87 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
3,895 |
2,706 |
$147.96 |
| 99201 |
|
1,333 |
1,319 |
$147.64 |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
580 |
459 |
$146.26 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
91 |
90 |
$145.53 |
| 77080 |
|
173 |
169 |
$143.22 |
| 73060 |
|
255 |
228 |
$142.06 |
| 90686 |
|
4,520 |
3,994 |
$140.60 |
| 92083 |
|
655 |
625 |
$139.97 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
6,065 |
3,869 |
$136.51 |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
30 |
29 |
$135.29 |
| 93017 |
|
105 |
99 |
$134.75 |
| 90696 |
|
604 |
488 |
$131.78 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
3,528 |
2,539 |
$129.94 |
| 97165 |
|
650 |
619 |
$129.35 |
| 86334 |
|
82 |
71 |
$120.03 |
| 92504 |
|
667 |
579 |
$116.57 |
| 83690 |
|
223 |
203 |
$105.70 |
| 73562 |
|
687 |
660 |
$105.66 |
| 88304 |
|
1,319 |
1,297 |
$103.01 |
| 87338 |
|
1,527 |
1,352 |
$99.49 |
| 81000 |
|
2,802 |
2,499 |
$97.83 |
| 86225 |
|
205 |
203 |
$95.66 |
| 90648 |
|
685 |
602 |
$92.52 |
| 91300 |
|
1,095 |
922 |
$91.00 |
| 90653 |
|
415 |
374 |
$90.18 |
| 94729 |
|
561 |
559 |
$89.24 |
| 96415 |
|
20 |
12 |
$85.54 |
| 29405 |
|
12 |
12 |
$84.41 |
| 81002 |
|
2,639 |
2,402 |
$82.16 |
| 86360 |
|
267 |
264 |
$79.69 |
| J1644 |
Injection, heparin sodium, per 1000 units |
7,651 |
2,791 |
$77.45 |
| 59025 |
Fetal non-stress test |
953 |
737 |
$77.44 |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
421 |
388 |
$76.97 |
| 94010 |
|
1,131 |
1,128 |
$74.96 |
| 90746 |
|
598 |
538 |
$74.09 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
5,246 |
2,683 |
$72.56 |
| 90700 |
|
605 |
508 |
$72.04 |
| 99234 |
|
13 |
13 |
$68.20 |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
113 |
99 |
$65.66 |
| 83615 |
|
57 |
50 |
$65.10 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
5,901 |
4,259 |
$63.81 |
| J1630 |
Injection, haloperidol, up to 5 mg |
1,235 |
973 |
$62.36 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,807 |
1,515 |
$61.83 |
| 31575 |
|
1,746 |
1,662 |
$59.40 |
| 88173 |
|
202 |
189 |
$56.87 |
| 84550 |
|
289 |
262 |
$53.96 |
| 82248 |
|
347 |
341 |
$53.45 |
| 82962 |
|
5,300 |
3,621 |
$51.45 |
| 87210 |
|
1,562 |
1,458 |
$50.70 |
| 84155 |
|
243 |
218 |
$50.40 |
| 92283 |
|
15 |
15 |
$50.37 |
| 97535 |
Self-care/home management training, each 15 minutes |
108 |
87 |
$50.31 |
| 86920 |
|
3,010 |
2,486 |
$49.72 |
| 73120 |
|
190 |
183 |
$48.45 |
| 86304 |
|
59 |
50 |
$47.80 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
1,784 |
1,712 |
$47.63 |
| 97164 |
|
32 |
29 |
$47.32 |
| 72110 |
|
13 |
12 |
$47.25 |
| 73502 |
|
97 |
94 |
$46.60 |
| 95816 |
|
150 |
150 |
$45.10 |
| 92555 |
|
197 |
148 |
$43.83 |
| 92235 |
|
29 |
27 |
$40.86 |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
36 |
36 |
$40.00 |
| 83026 |
|
6,480 |
5,804 |
$37.63 |
| 72040 |
|
60 |
53 |
$37.27 |
| 92579 |
|
50 |
39 |
$36.48 |
| 84156 |
|
256 |
238 |
$36.16 |
| 99173 |
|
494 |
461 |
$34.61 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
10,294 |
8,474 |
$34.07 |
| J2060 |
Injection, lorazepam, 2 mg |
1,792 |
1,270 |
$33.70 |
| S5551 |
Insulin, most rapid onset (lispro or aspart); 5 units |
4,474 |
1,351 |
$31.60 |
| P9011 |
Blood, split unit |
358 |
290 |
$30.14 |
| 84703 |
|
127 |
106 |
$29.65 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
13,768 |
12,761 |
$29.34 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
7,949 |
7,641 |
$27.54 |
| J7050 |
Infusion, normal saline solution, 250 cc |
12,599 |
7,907 |
$27.54 |
| S0164 |
Injection, pantoprazole sodium, 40 mg |
1,243 |
220 |
$27.48 |
| 97116 |
|
94 |
80 |
$25.75 |
| 83883 |
|
16 |
12 |
$24.18 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
3,365 |
2,711 |
$23.22 |
| 85008 |
|
194 |
178 |
$23.20 |
| 87205 |
|
1,764 |
1,572 |
$19.25 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
1,004 |
746 |
$18.59 |
| 83001 |
|
24 |
24 |
$18.35 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
5,110 |
4,594 |
$17.49 |
| 70486 |
|
12 |
12 |
$15.66 |
| 0300 |
|
6,085 |
5,274 |
$15.57 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
1,230 |
478 |
$14.48 |
| 98968 |
|
825 |
766 |
$14.46 |
| 88108 |
|
664 |
623 |
$14.43 |
| J2916 |
Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg |
2,324 |
933 |
$13.92 |
| 82784 |
|
59 |
49 |
$12.98 |
| 85044 |
|
109 |
100 |
$12.96 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,268 |
1,171 |
$11.02 |
| 83721 |
|
25 |
25 |
$10.40 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
953 |
684 |
$10.19 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
983 |
951 |
$9.92 |
| 96127 |
|
16 |
16 |
$9.52 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
3,473 |
1,650 |
$8.12 |
| 87070 |
|
727 |
614 |
$7.51 |
| 87015 |
|
15 |
14 |
$6.61 |
| 87081 |
|
2,171 |
1,926 |
$5.62 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
8,124 |
1,743 |
$5.26 |
| 87581 |
|
46 |
44 |
$4.95 |
| 85018 |
|
33 |
31 |
$4.70 |
| 94200 |
|
131 |
131 |
$4.43 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
652 |
493 |
$4.13 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
3,447 |
2,523 |
$1.43 |
| 86708 |
|
45 |
42 |
$0.64 |
| 0130 |
|
2,838 |
879 |
$0.00 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
2,801 |
1,743 |
$0.00 |
| S5550 |
Insulin, rapid onset, 5 units |
1,360 |
818 |
$0.00 |
| 88300 |
|
228 |
223 |
$0.00 |
| 99386 |
|
710 |
697 |
$0.00 |
| J0610 |
Injection, calcium gluconate (fresenius kabi), per 10 ml |
724 |
475 |
$0.00 |
| J1940 |
Injection, furosemide, up to 20 mg |
2,873 |
1,367 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
5,916 |
4,721 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
1,815 |
982 |
$0.00 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
1,377 |
1,347 |
$0.00 |
| 99243 |
|
796 |
791 |
$0.00 |
| J9202 |
Goserelin acetate implant, per 3.6 mg |
637 |
544 |
$0.00 |
| 3052F |
|
990 |
899 |
$0.00 |
| 3079F |
|
4,744 |
4,486 |
$0.00 |
| 0110 |
|
789 |
580 |
$0.00 |
| Q5103 |
Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg |
1,017 |
900 |
$0.00 |
| 94760 |
|
255 |
108 |
$0.00 |
| 99385 |
|
769 |
758 |
$0.00 |
| J3480 |
Injection, potassium chloride, per 2 meq |
1,288 |
693 |
$0.00 |
| 83605 |
|
305 |
180 |
$0.00 |
| 80422 |
|
2,220 |
1,827 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
168 |
168 |
$0.00 |
| 99241 |
|
18 |
18 |
$0.00 |
| 87040 |
|
164 |
96 |
$0.00 |
| 0636 |
|
3,484 |
3,242 |
$0.00 |
| J9045 |
Injection, carboplatin, 50 mg |
213 |
151 |
$0.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
546 |
521 |
$0.00 |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
97 |
49 |
$0.00 |
| A9152 |
Single vitamin/mineral/trace element, oral, per dose, not otherwise specified |
241 |
223 |
$0.00 |
| 98967 |
|
755 |
703 |
$0.00 |
| T1014 |
Telehealth transmission, per minute, professional services bill separately |
1,723 |
1,488 |
$0.00 |
| 3074F |
|
24,008 |
20,917 |
$0.00 |
| 99024 |
|
1,739 |
1,639 |
$0.00 |
| J9267 |
Injection, paclitaxel, 1 mg |
168 |
108 |
$0.00 |
| 90656 |
|
2,187 |
2,034 |
$0.00 |
| 96161 |
|
1,287 |
1,140 |
$0.00 |
| 0771 |
|
6,149 |
5,471 |
$0.00 |
| 31231 |
|
193 |
184 |
$0.00 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
75 |
68 |
$0.00 |
| 80047 |
|
14 |
13 |
$0.00 |
| 99384 |
|
55 |
55 |
$0.00 |
| 59414 |
|
333 |
330 |
$0.00 |
| 93930 |
|
13 |
12 |
$0.00 |
| 99606 |
|
115 |
85 |
$0.00 |
| J1950 |
Injection, leuprolide acetate (for depot suspension), per 3.75 mg |
56 |
54 |
$0.00 |
| J3490 |
Unclassified drugs |
1,201 |
1,149 |
$0.00 |
| C1781 |
Mesh (implantable) |
12 |
12 |
$0.00 |
| 36410 |
|
96 |
93 |
$0.00 |
| 99383 |
|
135 |
134 |
$0.00 |
| 99174 |
|
93 |
80 |
$0.00 |
| 73503 |
|
37 |
36 |
$0.00 |
| 19083 |
|
120 |
111 |
$0.00 |
| J3430 |
Injection, phytonadione (vitamin k), per 1 mg |
12 |
12 |
$0.00 |
| 3075F |
|
6,618 |
6,134 |
$0.00 |
| 93922 |
|
64 |
63 |
$0.00 |
| 88187 |
|
255 |
221 |
$0.00 |
| 3080F |
|
1,705 |
1,612 |
$0.00 |
| 81015 |
|
636 |
530 |
$0.00 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
74 |
53 |
$0.00 |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
14 |
14 |
$0.00 |
| 86762 |
|
25 |
25 |
$0.00 |
| 74230 |
|
12 |
12 |
$0.00 |
| 90674 |
|
120 |
115 |
$0.00 |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
64 |
63 |
$0.00 |
| 3044F |
|
9,205 |
8,522 |
$0.00 |
| 73560 |
|
86 |
83 |
$0.00 |
| 86593 |
|
12 |
12 |
$0.00 |
| J0461 |
Injection, atropine sulfate, 0.01 mg |
37 |
24 |
$0.00 |
| 1111F |
|
18,889 |
15,958 |
$0.00 |
| S5553 |
Insulin, long acting; 5 units |
83 |
37 |
$0.00 |
| 76519 |
|
16 |
15 |
$0.00 |
| 99406 |
|
13 |
12 |
$0.00 |
| 96910 |
|
34 |
12 |
$0.00 |
| J9299 |
Injection, nivolumab, 1 mg |
15 |
12 |
$0.00 |
| 84540 |
|
14 |
12 |
$0.00 |
| 90716 |
|
53 |
42 |
$0.00 |
| 91307 |
|
25 |
16 |
$0.00 |
| 99465 |
|
13 |
13 |
$0.00 |
| 93280 |
|
13 |
13 |
$0.00 |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
12 |
12 |
$0.00 |
| 59410 |
|
12 |
12 |
$0.00 |
| 90743 |
|
33 |
28 |
$0.00 |
| 1220F |
|
22 |
22 |
$0.00 |
| J0456 |
Injection, azithromycin, 500 mg |
19 |
13 |
$0.00 |
| 93990 |
|
13 |
12 |
$0.00 |
| 74330 |
|
13 |
13 |
$0.00 |
| 84300 |
|
23 |
13 |
$0.00 |
| 85060 |
|
384 |
334 |
$0.00 |
| C9257 |
Injection, bevacizumab, 0.25 mg |
917 |
862 |
$0.00 |
| G9920 |
Screening performed and negative |
5,806 |
5,349 |
$0.00 |
| 84145 |
|
20 |
13 |
$0.00 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
7,882 |
6,015 |
$0.00 |
| J3489 |
Injection, zoledronic acid, 1 mg |
279 |
242 |
$0.00 |
| 36600 |
|
1,394 |
1,037 |
$0.00 |
| Q0144 |
Azithromycin dihydrate, oral, capsules/powder, 1 gram |
245 |
225 |
$0.00 |
| 3051F |
|
1,794 |
1,638 |
$0.00 |
| 86922 |
|
193 |
162 |
$0.00 |
| 96160 |
|
973 |
900 |
$0.00 |
| 86003 |
|
30 |
28 |
$0.00 |
| J0694 |
Injection, cefoxitin sodium, 1 gm |
101 |
98 |
$0.00 |
| 94150 |
|
26 |
26 |
$0.00 |
| 3046F |
|
1,571 |
1,432 |
$0.00 |
| 98966 |
|
1,143 |
1,006 |
$0.00 |
| 3077F |
|
6,157 |
5,552 |
$0.00 |
| 77062 |
|
101 |
100 |
$0.00 |
| 93770 |
|
56 |
54 |
$0.00 |
| J9263 |
Injection, oxaliplatin, 0.5 mg |
250 |
163 |
$0.00 |
| 97163 |
|
114 |
109 |
$0.00 |
| J9271 |
Injection, pembrolizumab, 1 mg |
321 |
268 |
$0.00 |
| J9190 |
Injection, fluorouracil, 500 mg |
139 |
71 |
$0.00 |
| 90734 |
|
900 |
817 |
$0.00 |
| 0120 |
|
787 |
271 |
$0.00 |
| G9919 |
Screening performed and positive and provision of recommendations |
208 |
190 |
$0.00 |
| J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) |
1,624 |
1,013 |
$0.00 |
| J7642 |
Glycopyrrolate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram |
1,895 |
1,832 |
$0.00 |
| 99245 |
|
646 |
620 |
$0.00 |
| 90707 |
|
30 |
23 |
$0.00 |
| 99382 |
|
215 |
196 |
$0.00 |
| 92611 |
|
12 |
12 |
$0.00 |
| 0731 |
|
62 |
62 |
$0.00 |
| 99421 |
|
44 |
43 |
$0.00 |
| 3078F |
|
27,573 |
23,586 |
$0.00 |
| S0030 |
Injection, metronidazole, 500 mg |
650 |
229 |
$0.00 |
| 90791 |
Psychiatric diagnostic evaluation |
44 |
44 |
$0.00 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
185 |
178 |
$0.00 |
| J2590 |
Injection, oxytocin, up to 10 units |
183 |
152 |
$0.00 |
| 83655 |
|
56 |
56 |
$0.00 |
| 88302 |
|
14 |
14 |
$0.00 |
| 97168 |
|
80 |
54 |
$0.00 |
| 80348 |
|
214 |
124 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
152 |
152 |
$0.00 |
| 90661 |
|
262 |
249 |
$0.00 |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
107 |
57 |
$0.00 |
| 36555 |
|
37 |
25 |
$0.00 |
| 93970 |
|
51 |
51 |
$0.00 |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
79 |
77 |
$0.00 |
| 99605 |
|
20 |
14 |
$0.00 |
| 51741 |
|
97 |
89 |
$0.00 |
| 94726 |
|
63 |
63 |
$0.00 |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
175 |
169 |
$0.00 |
| J9217 |
Leuprolide acetate (for depot suspension), 7.5 mg |
66 |
62 |
$0.00 |
| 91312 |
|
40 |
34 |
$0.00 |
| 93041 |
|
943 |
481 |
$0.00 |
| 92552 |
|
29 |
28 |
$0.00 |
| G0390 |
Trauma response team associated with hospital critical care service |
29 |
29 |
$0.00 |
| 93224 |
|
15 |
15 |
$0.00 |
| Q5118 |
Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg |
64 |
37 |
$0.00 |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
23 |
23 |
$0.00 |
| S0028 |
Injection, famotidine, 20 mg |
240 |
183 |
$0.00 |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
47 |
43 |
$0.00 |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
87 |
87 |
$0.00 |
| 94727 |
|
14 |
14 |
$0.00 |
| 86765 |
|
69 |
67 |
$0.00 |
| Q5116 |
Injection, trastuzumab-qyyp, biosimilar, (trazimera), 10 mg |
95 |
63 |
$0.00 |
| J0612 |
Injection, calcium gluconate, not otherwise specified, 10 mg |
31 |
28 |
$0.00 |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
24 |
24 |
$0.00 |
| J0692 |
Injection, cefepime hydrochloride, 500 mg |
59 |
17 |
$0.00 |
| 67028 |
Intravitreal injection of a pharmacologic agent |
15 |
14 |
$0.00 |
| J1953 |
Injection, levetiracetam, 10 mg |
25 |
12 |
$0.00 |
| J1453 |
Injection, fosaprepitant, 1 mg |
50 |
26 |
$0.00 |
| J7297 |
Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg |
74 |
67 |
$0.00 |
| 77012 |
|
12 |
12 |
$0.00 |
| 96900 |
|
192 |
38 |
$0.00 |
| J9060 |
Injection, cisplatin, powder or solution, 10 mg |
29 |
12 |
$0.00 |
| J1750 |
Injection, iron dextran, 50 mg |
30 |
25 |
$0.00 |
| 90473 |
|
24 |
24 |
$0.00 |
| 75989 |
|
16 |
16 |
$0.00 |
| 0124A |
|
45 |
38 |
$0.00 |
| 73070 |
|
14 |
12 |
$0.00 |
| 89050 |
|
15 |
13 |
$0.00 |
| J3250 |
Injection, trimethobenzamide hcl, up to 200 mg |
20 |
12 |
$0.00 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
19 |
19 |
$0.00 |
| 85014 |
|
13 |
12 |
$0.00 |
| 86039 |
|
12 |
12 |
$0.00 |